These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2742277)

  • 1. Developmental consequences of prenatal exposure to methadone.
    Hans SL
    Ann N Y Acad Sci; 1989; 562():195-207. PubMed ID: 2742277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal methadone exposure and child developmental outcomes in 2-year-old children.
    Levine TA; Davie-Gray A; Kim HM; Lee SJ; Woodward LJ
    Dev Med Child Neurol; 2021 Sep; 63(9):1114-1122. PubMed ID: 33462809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal and developmental outcome of infants exposed to methadone in-utero.
    Kaltenbach K; Finnegan LP
    Neurotoxicol Teratol; 1987; 9(4):311-3. PubMed ID: 3683349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal methadone exposure: effects on behavior in early infancy.
    Johnson HL; Rosen TS
    Pediatr Pharmacol (New York); 1982; 2(2):113-20. PubMed ID: 12760403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting head growth and intellectual function in children of drug addicts.
    Lifschitz MH; Wilson GS; Smith EO; Desmond MM
    Pediatrics; 1985 Feb; 75(2):269-74. PubMed ID: 3969327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine.
    Konijnenberg C; Sarfi M; Melinder A
    Early Hum Dev; 2016 Oct; 101():91-7. PubMed ID: 27614330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of offspring born to methadone-maintained women. III. Effects of multiple risk factors on development at 4, 8, and 12 months.
    Marcus J; Hans SL; Jeremy RJ
    Am J Drug Alcohol Abuse; 1984; 10(2):195-207. PubMed ID: 6475887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal methadone exposure is associated with altered neonatal brain development.
    Monnelly VJ; Anblagan D; Quigley A; Cabez MB; Cooper ES; Mactier H; Semple SI; Bastin ME; Boardman JP
    Neuroimage Clin; 2018; 18():9-14. PubMed ID: 29326869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal cocaine exposure, child development, and the compromising effects of cumulative risk.
    Tronick EZ; Beeghly M
    Clin Perinatol; 1999 Mar; 26(1):151-71. PubMed ID: 10214547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study of offspring born to methadone-maintained women. II. Dyadic interaction and infant behavior at 4 months.
    Bernstein V; Jeremy RJ; Hans SL; Marcus J
    Am J Drug Alcohol Abuse; 1984; 10(2):161-93. PubMed ID: 6475886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age.
    Messinger DS; Bauer CR; Das A; Seifer R; Lester BM; Lagasse LL; Wright LL; Shankaran S; Bada HS; Smeriglio VL; Langer JC; Beeghly M; Poole WK
    Pediatrics; 2004 Jun; 113(6):1677-85. PubMed ID: 15173491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental outcome of children born to methadone maintained women: a review of longitudinal studies.
    Kaltenbach K; Finnegan LP
    Neurobehav Toxicol Teratol; 1984; 6(4):271-5. PubMed ID: 6392916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of early developmental deficits in infants with prenatal heroin, methadone, and other opioid exposure.
    Beckwith AM; Burke SA
    Clin Pediatr (Phila); 2015 Apr; 54(4):328-35. PubMed ID: 25189695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children of methadone-dependent women: developmental outcomes.
    de Cubas MM; Field T
    Am J Orthopsychiatry; 1993 Apr; 63(2):266-76. PubMed ID: 7683453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone and heroin during pregnancy: a review of behavioral effects in human and animal offspring.
    Hutchings DE
    Neurobehav Toxicol Teratol; 1982; 4(4):429-34. PubMed ID: 7121694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone during pregnancy: the search for a valid animal model.
    Hutchings DE; Zmitrovich A; Church S; Malowany D
    Ann Ist Super Sanita; 1993; 29(3):439-44. PubMed ID: 8172463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal nonnarcotic substance abuse during pregnancy: effects on infant development.
    Chasnoff IJ; Schnoll SH; Burns WJ; Burns K
    Neurobehav Toxicol Teratol; 1984; 6(4):277-80. PubMed ID: 6514088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine.
    Bier JB; Finger AS; Bier BA; Johnson TA; Coyle MG
    J Perinatol; 2015 Aug; 35(8):656-9. PubMed ID: 25836317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyads at risk: methadone-maintained women and their four-month-old infants.
    Jeremy RJ; Bernstein VJ
    Child Dev; 1984 Aug; 55(4):1141-54. PubMed ID: 6488949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early inhibitory control and working memory abilities of children prenatally exposed to methadone.
    Levine TA; Woodward LJ
    Early Hum Dev; 2018 Jan; 116():68-75. PubMed ID: 29195088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.